DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Osborne Partners Capital Management LLC

Osborne Partners Capital Management LLC cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 298,880 shares of the medical instruments supplier's stock after selling 33,543 shares during the quarter. Osborne Partners Capital Management LLC owned approximately 0.15% of DENTSPLY SIRONA worth $5,673,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of XRAY. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $27,000. Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. Finally, Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the third quarter worth approximately $42,000. 95.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

XRAY has been the subject of a number of recent analyst reports. Leerink Partnrs cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Barrington Research decreased their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a report on Friday, November 8th. Finally, Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Ten investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $26.33.

DENTSPLY SIRONA Price Performance

XRAY stock traded up $0.10 during midday trading on Wednesday, reaching $19.39. The stock had a trading volume of 920,436 shares, compared to its average volume of 2,330,294. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $34.91. The company has a market cap of $3.86 billion, a price-to-earnings ratio of -9.37, a price-to-earnings-growth ratio of 1.88 and a beta of 0.96. The company's fifty day simple moving average is $19.15 and its 200 day simple moving average is $22.33. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. The ex-dividend date was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.30%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.